null - FindTrial

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2016-000050-36-FR

Enrollment

Unknown

Registered

2016-05-04

Start date

2016-04-15

Completion date

Unknown

Last updated

2016-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 19.0 Level: LLT Classification code 10036286 Term: Post-operative pain System Organ Class: 100000004863

Interventions

Trade Name: Lévobupivacaïne Product Name: Lévobupivacaïne Pharmaceutical Form: Solution for infusion INN or Proposed INN: Lévobupivacaïne CAS Number: 27262-48-2 Other descriptive name: LEVOBUPIVACAINE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 41 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 41

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactChef de projets recherche

CHU de DIJON

catherine.renaud@chu-dijon.fr038029315333

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026